Galderma is certainly the heavyweight for rosacea treatments and skincare. Rosacea sufferers will be familiar with Metrogel 1% and Oracea as well as their Cetaphil skincare range. More recently Galderma has gained approval for Mirvaso and also has CD5024/Ivermectin in development.

Recent Rosacea Blog Posts

Oracea launches as Apprilon in Canada

A press release today from Galderma confirms that they will be marketing the product known in the US as Oracea under the name Apprilon in Canada. All of the same precautions and prescription details for Apprilon are the same as for Oracea, i.e. it is the exact same modified-release capsule, 40 mg doxycycline. First of […]

Continue Reading

A patent application has surfaced that shows Galderma claiming an invention that is a diagnostic test for rosacea. A patent application does not guarantee that any particular invention or discovery is valid, just that a company wants to claim the rights to the intellectual property it contains. Indeed some patents will be filed purely to […]

Continue Reading

Oracea available as Efracea (now Apprilon) in Canada

This seems to have gone mostly unnoticed by rosacea sufferers, but in early 2012 Health Canada approved Efracea as a treatment for the papules and pustules of rosacea. Called a Summary Basis of Decision for Efracea, Health Canada decreed: Summary Basis of Decision (SBD) for EFRACEA EFRACEA Doxycycline monohydrate, 40 mg capsule Galderma Canada Inc. […]

Continue Reading

Galderma Patent Portfolio: Dipyridyl Compounds

The pharmaceutical giant Galderma continues to build its war chest of rosacea patents. A newly surfaced patent covers treating rosacea with a dipyrdyl compound. A brief online search for Galderma-assigned patents that mention rosacea reveals almost 2000 matches, with about 11,000 patents being assigned to Galderma Research & Development overall. These numbers are likely to be […]

Continue Reading

Dermatology Times today has an article that confirms some insights into the recent Phase II study into the safety and efficacy of different strengths of the Sansrosa Gel. The article adds some personal insights into the trial from the principal investigator, Dr. Joseph Fowler MD. This is not the most recent news as Rosacea News […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.